Aurobindo, Hetero, and Vivimed Class Action Settlements in Nebraska
Aurobindo, Hetero, and Vivimed class action settlements that covered Nebraska residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Nebraska residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Nebraska Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Nebraska
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Nebraska residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed pharmaceutical companies have legal recourse through class action settlements. These three Indian pharmaceutical manufacturers supplied valsartan, losartan, and irbesartan medications containing NDMA and NDEA carcinogens to U.S. markets, including Nebraska pharmacies and healthcare systems. Nebraska's Uniform Deceptive Trade Practices Act provides additional consumer protections beyond federal regulations, potentially strengthening claims for residents who purchased these contaminated medications. While these pharmaceutical companies don't maintain major manufacturing facilities in Nebraska, their products reached Nebraska consumers through national pharmacy chains like CVS, Walgreens, and regional distributors serving Nebraska's healthcare network. Nebraska follows federal class action procedures under Rule 23, meaning residents can participate in nationwide settlements without filing separate state claims. The state's four-year statute of limitations for product liability claims typically applies, though discovery rules may extend deadlines for those unaware of contamination until recent announcements. Nebraska residents should preserve prescription records and receipts to document their exposure to these recalled medications.
Aurobindo, Hetero, and Vivimed Settlements in Nebraska: FAQs
Can Nebraska residents participate in the $15.2M Aurobindo, Hetero, and Vivimed settlement for contaminated blood pressure medications?
Yes, Nebraska residents who purchased valsartan, losartan, or irbesartan medications manufactured by these companies between 2012-2019 are eligible for the settlement. Nebraska's participation follows federal class action rules, so residents don't need to file separate state claims to receive compensation.
Does Nebraska's Consumer Protection Act provide additional remedies beyond the class action settlement for contaminated Aurobindo, Hetero, and Vivimed medications?
Nebraska's Uniform Deceptive Trade Practices Act may provide additional grounds for individual lawsuits if residents can prove deceptive practices in medication marketing or distribution. However, most Nebraska residents will find the class action settlement provides the most practical path to compensation without individual litigation costs.
What documentation do Nebraska residents need to file claims against Aurobindo, Hetero, and Vivimed for contaminated blood pressure medications?
Nebraska residents should gather prescription records, pharmacy receipts, and medical records showing they took recalled valsartan, losartan, or irbesartan medications. Nebraska pharmacies like Hy-Vee, CVS, and local independents should have purchase records if original receipts are unavailable.
Tips for Nebraska Residents Filing Aurobindo, Hetero, and Vivimed Claims
Nebraska residents filing Aurobindo, Hetero, and Vivimed claims should contact their pharmacies immediately to obtain prescription records showing purchase of recalled valsartan, losartan, or irbesartan medications. Document any medical issues experienced while taking these medications through your healthcare provider. Nebraska's statute of limitations provides four years from discovery of harm, but filing promptly ensures access to the $15.2M settlement fund. Keep copies of all medical records and prescription bottles with lot numbers if available. Consider consulting Nebraska attorneys experienced in pharmaceutical litigation, as they understand state-specific consumer protection laws that may provide additional remedies beyond federal class action settlements.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
